期刊文献+

UPLC-MS/MS法测定人血浆中的醋酸甲地孕酮

Determination of Megestrol Acetate in Human Plasma by UPLC-MS/MS
下载PDF
导出
摘要 目的:建立超高效液相色谱-串联质谱法(UPLC-MS/MS)测定人血浆中醋酸甲地孕酮的浓度。方法:采用蛋白沉淀法预处理血浆样本,沉淀剂为甲醇。采用Waters BEH C_(18)色谱柱(50 mm×2.1 mm,1.7μm),流动相A为含0.1%甲酸和10 mmol·L^(-1)乙酸铵的水溶液,流动相B为甲醇,梯度洗脱,流速0.3 ml·min^(-1),柱温40℃,进样量1μl。结果:醋酸甲地孕酮的线性范围为1~400 ng·ml^(-1);定量下限为1 ng·ml^(-1);批内精密度RSD均≤6.50%,批间精密度RSD均≤5.86%;醋酸甲地孕酮的提取回收率≥90.93%。结论:所用方法简便快速、准确度高、灵敏度好,适用于测定人血浆中甲地孕酮的浓度。 Objective:To establish a UPLC-MS/MS method for determining megestrol acetate in human plasma.Methods:The samples were treated by protein precipitation with methanol.The chromatographic column was Waters BEH(50.0 mm×2.1 mm,1.7μm).Megestrol acetate was determined by gradient elution with 0.1%aqueous formic acid containing 10 mmol·L^(-1)ammonium acetate as mobile phase A and methanol as mobile phase B.The flow rate was 0.3 ml·min^(-1)with the column temperature at 40℃,and the injection volume of 1μl.Results:The standard curve was within the range of 1-400 ng·ml^(-1).The LLOQ was 1 ng·ml^(-1).All the RSDs of intra-batch precision were not more than 6.50%,and all the RSDs of inter-batch precision were not more than 5.86%.The recovery of megestrol acetate was not less than 90.93%.Conclusion:The method is easy,rapid,accurate and sensitive.It is suitable for determining megestrol acetate in human plasma.
作者 石玲子 刘娟 杨姗姗 吴强 Shi Lingzi;Liu Juan;Yang Shanshan;Wu Qiang(Sichuan Institute for Drug Control,NMPA Key Laboratory for Technical Research on Drug Products in vitro and in vivo Correlation,Chengdu 611731,China)
出处 《中国药师》 CAS 2022年第11期2025-2028,共4页 China Pharmacist
关键词 孕激素 醋酸甲地孕酮 超高效液相色谱-串联质谱法 人血浆 蛋白沉淀法 Progestin Megestrol acetate UPLC-MS/MS Human plasma Protein precipitation
  • 相关文献

参考文献3

二级参考文献27

  • 1马星航 王杰民 秦芝玲等.血浆中醋酸甲地孕酮浓度的测定及其药物动力学参数[J].上海医科大学学报,1986,(13):416-416.
  • 2Logmans A, Mous HVH, Bontenbal M, et al. Results of curettage for postmenopausal vaginal bleeding in women treated with tamoxifen and megestrol acetate for progres- sive metastatic breast carcinoma. Eur J Obstet Gyn R B, 1994,56(3):173-176.
  • 3Jonat W, Howell A, Blomqvist C, et al. A randomized trial comparing two doses of the new selective aromatase inhibitor anastrozole (arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer. Euro J Cancer, 1996,32(3):404-412.
  • 4Stuart NS, Warwick J, Blackledge GR, et al. A random- ised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer. Euro J Cancer, 1996,32(11): 1888-1892.
  • 5Licchetta A, Correale P, Migali C, et al. Oral metronomic chemo-hormonal-therapy of metastatic breast cancer with cyclophosphamide and megestrol acetate. J Chemother, 2010,22(3) :201-204.
  • 6Mateen F, Jatoi A. Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients. Clin Nutr, 2006,25(5):711-715.
  • 7Westman G, Bergman B, Albertsson M, et al. Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial. Euro J Cancer, 1999,35(4): 586-595.
  • 8De Conno F, Martini C, Zecca E, et al. Megestrol acetate for anorexia in patients with far-advanced cancer: a dou- ble-blind controlled clinical trial. Euro J Cancer, 1998,34(11):1705-1709.
  • 9Pascual Lopez A, Roque i Figuls M, Urrutia Cuchi G, et al. Systematic review of megestrol acetate in the treat- ment of anorexia-cachxia syndrome. J Pain Sym Man, 2004,27(4):360-369.
  • 10Fietkau R, Riepl M, Kettner H, et al. Supportive use of magestrol acetate in patients with head and neck cancer during radio(chemo)therapy. Euro J Cancer, 1997,33(1): 75-79.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部